Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 114
Filter
1.
researchsquare; 2024.
Preprint in English | PREPRINT-RESEARCHSQUARE | ID: ppzbmed-10.21203.rs.3.rs-3878182.v1

ABSTRACT

Metaverse in effective surveillance of outbreaks of emerging infectious diseases such as COVID-19 opens a new avenue for precision and efficient contact tracing, quarantine, and isolation. We adopted a digital twin model to generate digital threads for tracing and tracking virtual data on the cycle threshold (Ct) values of the repeated RT-PCR with parameters learned from real-world (physical) data fitted with Markov machine learning algorithms. Such a digital twin method is demonstrated with COVID-19 community-acquired outbreaks of the Alpha and Omicron Variants of Concern (VOCs) in Taiwan. The personalized dynamics of Ct-defined transitions were derived from the digital threads of the two community-acquired outbreaks to guide precision contact tracing, quarantine, and isolation of both Alpha and Omicron VOCs outbreaks. Metaverse surveillance with such a Ct-guided digital twin model is supposed to be useful for timely containing the spread of emerging infectious diseases in the future.


Subject(s)
COVID-19 , Learning Disabilities , Communicable Diseases, Emerging
2.
researchsquare; 2023.
Preprint in English | PREPRINT-RESEARCHSQUARE | ID: ppzbmed-10.21203.rs.3.rs-3127298.v1

ABSTRACT

We used a Bayesian competing four-state Markov model to explore how viral shedding in terms of cycle threshold (Ct) value makes relative contribution between persistent and non-persistent asymptomatic mode, and whether it affects the subsequent progression to show symptoms. The proposed model was applied to data from two large outbreaks on Alpha and Omicron variants of concern (VOCs) in Changhua, Taiwan. A multistate Markov exponential regression model was proposed for quantifying the odds ratio (OR) of viral shedding measured by cycle threshold (Ct). A Bayesian Markov Chain Monte Carlo (MCMC) method was used for estimating the parameters of the posterior distribution. The estimated results show that developing non-persistent asymptomatic mode relative to persistent asymptomatic mode was reduced by 14% (adjusted OR = 0.86, 95% CI: 0.81–0.92) per one increasing unit of Ct for Alpha VOC, whereas these figures were shrunk to 5% (aOR = 0.95, 95% CI: 0.93–0.98) for Omicron VOC. Similar significant gradient relationships were also observed between three viral load levels. Similar, but not statistically significant, dose-response effects of viral load on the progression to symptoms for non-persistent asymptomatic mode were observed. The application of statistical model helps elucidate the pathways of SARS-CoV-2 infectious process associated with viral shedding that demonstrate viral shedding plays a crucial role in determining the path of either non-persistent or persistent asymptomatic mode in a dose-response manner, which was more pronounced for the Alpha than the Omicron. Modelling such a multistate infectious process with two competing pathways would provide a new insight into the transmissibility and the duration of insidious infection before onset of symptom and the deployment of precision containment measures with a better use of the Ct value as virologic surveillance for projecting the individual epidemic course.


Subject(s)
COVID-19 , Infections
3.
Commun Med (Lond) ; 3(1): 81, 2023 Jun 12.
Article in English | MEDLINE | ID: covidwho-20241045

ABSTRACT

BACKGROUND: Acute kidney injury (AKI) is a known complication of COVID-19 and is associated with an increased risk of in-hospital mortality. Unbiased proteomics using biological specimens can lead to improved risk stratification and discover pathophysiological mechanisms. METHODS: Using measurements of ~4000 plasma proteins in two cohorts of patients hospitalized with COVID-19, we discovered and validated markers of COVID-associated AKI (stage 2 or 3) and long-term kidney dysfunction. In the discovery cohort (N = 437), we identified 413 higher plasma abundances of protein targets and 30 lower plasma abundances of protein targets associated with COVID-AKI (adjusted p < 0.05). Of these, 62 proteins were validated in an external cohort (p < 0.05, N = 261). RESULTS: We demonstrate that COVID-AKI is associated with increased markers of tubular injury (NGAL) and myocardial injury. Using estimated glomerular filtration (eGFR) measurements taken after discharge, we also find that 25 of the 62 AKI-associated proteins are significantly associated with decreased post-discharge eGFR (adjusted p < 0.05). Proteins most strongly associated with decreased post-discharge eGFR included desmocollin-2, trefoil factor 3, transmembrane emp24 domain-containing protein 10, and cystatin-C indicating tubular dysfunction and injury. CONCLUSIONS: Using clinical and proteomic data, our results suggest that while both acute and long-term COVID-associated kidney dysfunction are associated with markers of tubular dysfunction, AKI is driven by a largely multifactorial process involving hemodynamic instability and myocardial damage.


Acute kidney injury (AKI) is a sudden, sometimes fatal, episode of kidney failure or damage. It is a known complication of COVID-19, albeit through unclear mechanisms. COVID-19 is also associated with kidney dysfunction in the long term, or chronic kidney disease (CKD). There is a need to better understand which patients with COVID-19 are at risk of AKI or CKD. We measure levels of several thousand proteins in the blood of hospitalized COVID-19 patients. We discover and validate sets of proteins associated with severe AKI and CKD in these patients. The markers identified suggest that kidney injury in COVID-19 patients involves damage to kidney cells that reabsorb fluid from urine and reduced blood flow to the heart, causing damage to heart muscles. Our findings might help clinicians to predict kidney injury in patients with COVID-19, and to understand its mechanisms.

4.
Epidemiol Infect ; 151: e99, 2023 May 25.
Article in English | MEDLINE | ID: covidwho-20236964

ABSTRACT

Large gatherings of people on cruise ships and warships are often at high risk of COVID-19 infections. To assess the transmissibility of SARS-CoV-2 on warships and cruise ships and to quantify the effectiveness of the containment measures, the transmission coefficient (ß), basic reproductive number (R0), and time to deploy containment measures were estimated by the Bayesian Susceptible-Exposed-Infected-Recovered model. A meta-analysis was conducted to predict vaccine protection with or without non-pharmaceutical interventions (NPIs). The analysis showed that implementing NPIs during voyages could reduce the transmission coefficients of SARS-CoV-2 by 50%. Two weeks into the voyage of a cruise that begins with 1 infected passenger out of a total of 3,711 passengers, we estimate there would be 45 (95% CI:25-71), 33 (95% CI:20-52), 18 (95% CI:11-26), 9 (95% CI:6-12), 4 (95% CI:3-5), and 2 (95% CI:2-2) final cases under 0%, 10%, 30%, 50%, 70%, and 90% vaccine protection, respectively, without NPIs. The timeliness of strict NPIs along with implementing strict quarantine and isolation measures is imperative to contain COVID-19 cases in cruise ships. The spread of COVID-19 on ships was predicted to be limited in scenarios corresponding to at least 70% protection from prior vaccination, across all passengers and crew.


Subject(s)
COVID-19 , Humans , COVID-19/epidemiology , COVID-19/prevention & control , Ships , SARS-CoV-2 , Bayes Theorem , Travel , Disease Outbreaks/prevention & control , Quarantine
5.
Comput Biol Med ; 163: 107113, 2023 Jun 02.
Article in English | MEDLINE | ID: covidwho-20230910

ABSTRACT

The outbreak of coronavirus disease (COVID-19) in 2019 has highlighted the need for automatic diagnosis of the disease, which can develop rapidly into a severe condition. Nevertheless, distinguishing between COVID-19 pneumonia and community-acquired pneumonia (CAP) through computed tomography scans can be challenging due to their similar characteristics. The existing methods often perform poorly in the 3-class classification task of healthy, CAP, and COVID-19 pneumonia, and they have poor ability to handle the heterogeneity of multi-centers data. To address these challenges, we design a COVID-19 classification model using global information optimized network (GIONet) and cross-centers domain adversarial learning strategy. Our approach includes proposing a 3D convolutional neural network with graph enhanced aggregation unit and multi-scale self-attention fusion unit to improve the global feature extraction capability. We also verified that domain adversarial training can effectively reduce feature distance between different centers to address the heterogeneity of multi-center data, and used specialized generative adversarial networks to balance data distribution and improve diagnostic performance. Our experiments demonstrate satisfying diagnosis results, with a mixed dataset accuracy of 99.17% and cross-centers task accuracies of 86.73% and 89.61%.

6.
Financ Res Lett ; 55: 103960, 2023 Jul.
Article in English | MEDLINE | ID: covidwho-2319188

ABSTRACT

We categorize expansionary monetary policies based on interest rates, monetary easing, and liquidity decisions. We find that the stock market reacts positively to liquidity policy announcements by a more significant margin during and after the COVID-19 at market and industry levels compared with reactions to interest rate or monetary easing policy announcements. The economic consequences are large and persistent. Using firm characteristics as proxies for monetary policy transmission channels, we find that at firm level, the positive responses to liquidity policy announcements during the crisis are more pronounced for small and medium-sized businesses and non-state-owned enterprises relative to other enterprises.

7.
ISPRS International Journal of Geo-Information ; 12(4):152, 2023.
Article in English | ProQuest Central | ID: covidwho-2305509

ABSTRACT

Since late 2019, the explosive outbreak of Coronavirus Disease 19 (COVID-19) has emerged as a global threat, necessitating a worldwide overhaul of public health systems. One critical strategy to prevent virus transmission and safeguard public health, involves deploying Nucleic Acid Testing (NAT) sites. Nevertheless, determining the optimal locations for public NAT sites presents a significant challenge, due to the varying number of sites required in different regions, and the substantial influences of population, the population heterogeneity, and daily dynamics, on the effectiveness of fixed location schemes. To address this issue, this study proposes a data-driven framework based on classical location-allocation models and bi-objective optimization models. The framework optimizes the number and location of NAT sites, while balancing various cost constraints and adapting to population dynamics during different periods of the day. The bi-objective optimization process utilizes the Knee point identification (KPI) algorithm, which is computationally efficient and does not require prior knowledge. A case study conducted in Shenzhen, China, demonstrates that the proposed framework provides a broader service coverage area and better accommodates residents' demands during different periods, compared to the actual layout of NAT sites in the city. The study's findings can facilitate the rapid planning of primary healthcare facilities, and promote the development of sustainable healthy cities.

8.
Sci Rep ; 13(1): 6236, 2023 04 17.
Article in English | MEDLINE | ID: covidwho-2304268

ABSTRACT

Predicting COVID-19 severity is difficult, and the biological pathways involved are not fully understood. To approach this problem, we measured 4701 circulating human protein abundances in two independent cohorts totaling 986 individuals. We then trained prediction models including protein abundances and clinical risk factors to predict COVID-19 severity in 417 subjects and tested these models in a separate cohort of 569 individuals. For severe COVID-19, a baseline model including age and sex provided an area under the receiver operator curve (AUC) of 65% in the test cohort. Selecting 92 proteins from the 4701 unique protein abundances improved the AUC to 88% in the training cohort, which remained relatively stable in the testing cohort at 86%, suggesting good generalizability. Proteins selected from different COVID-19 severity were enriched for cytokine and cytokine receptors, but more than half of the enriched pathways were not immune-related. Taken together, these findings suggest that circulating proteins measured at early stages of disease progression are reasonably accurate predictors of COVID-19 severity. Further research is needed to understand how to incorporate protein measurement into clinical care.


Subject(s)
COVID-19 , Humans , COVID-19/diagnosis , Proteins , Risk Factors , Disease Progression , Retrospective Studies
9.
Computational and structural biotechnology journal ; 2023.
Article in English | EuropePMC | ID: covidwho-2269826

ABSTRACT

The SARS-CoV-2 virus, which causes the COVID-19, is rapidly accumulating mutations to adapt to the hosts. We collected SARS-CoV-2 sequence data from the end of 2019 to January 2023 to analyze for their evolutionary features during the pandemic. We found that most of the SARS-CoV-2 genes are undergoing negative purifying selection, while the spike protein gene (S-gene) is undergoing rapid positive selection. From the original strain to the alpha, delta and omicron variant types, the Ka/Ks of the S-gene increases, while the Ka/Ks within one variant type decreases over time. During the evolution, the codon usage did not evolve towards optimal translation and protein expression. In contrast, only S-gene mutations showed a remarkable trend on accumulating more positive charges. This facilitates the infection via binding human ACE2 for cell entry and binding furin for cleavage. Such a functional evolution emphasizes the survival strategy of SARS-CoV-2, and indicated new druggable target to contain the viral infection. The nearly fully positively-charged interaction surfaces indicated that the infectivity of SARS-CoV-2 virus may approach a limit. Graphical

10.
Human Resource Management ; 62(2):213-228, 2023.
Article in English | CINAHL | ID: covidwho-2282119

ABSTRACT

Many empirical studies have elucidated the antecedents and psychological mechanisms of employees' proactive behaviors. However, there is limited knowledge about how a human resource (HR) system helps employees proactively adjust to their changing work environment. Drawing on social exchange theory and event system theory, we developed a theoretical model to examine whether, how, and when perceptions of the HR system strength impact employee proactive behavior during crises. Results from a three‐wave time‐lagged survey of 305 employees in 65 teams in eight Chinese companies indicate that HR system strength creates a strong situation by alleviating employees' uncertainty about how to behave during crises, which stimulates employees' work engagement and subsequent proactive behaviors. Moreover, employees' perceptions of HR system strength are more likely to influence work engagement when employees perceive the COVID‐19 crisis as more severe. We discuss the theoretical and practical implications of the findings and outline important future research directions.

11.
Reproductive and Developmental Medicine ; 6(3):138-143, 2022.
Article in English | EuropePMC | ID: covidwho-2263418

ABSTRACT

The impact of coronavirus disease 2019 (COVID-19) on endometriosis (EM) is currently unclear. Here, we aimed to describe the potential influence of COVID-19 on the pathogenesis, clinical symptoms, and treatment of EM. The cytokine storm caused by COVID-19 may induce the occurrence and progression of EM, and immunosuppression of COVID-19 may help the ectopic endometrium escape from immune clearance. Consequently, the forced social isolation and the cancelation of non-emergency medical treatment during the COVID-19 pandemic aggravate anxiety and psychological pressure, which can aggravate the symptoms related to EM and delay routine medical services.

12.
Nat Metab ; 5(2): 248-264, 2023 02.
Article in English | MEDLINE | ID: covidwho-2287963

ABSTRACT

Obesity is a major risk factor for Coronavirus disease (COVID-19) severity; however, the mechanisms underlying this relationship are not fully understood. As obesity influences the plasma proteome, we sought to identify circulating proteins mediating the effects of obesity on COVID-19 severity in humans. Here, we screened 4,907 plasma proteins to identify proteins influenced by body mass index using Mendelian randomization. This yielded 1,216 proteins, whose effect on COVID-19 severity was assessed, again using Mendelian randomization. We found that an s.d. increase in nephronectin (NPNT) was associated with increased odds of critically ill COVID-19 (OR = 1.71, P = 1.63 × 10-10). The effect was driven by an NPNT splice isoform. Mediation analyses supported NPNT as a mediator. In single-cell RNA-sequencing, NPNT was expressed in alveolar cells and fibroblasts of the lung in individuals who died of COVID-19. Finally, decreasing body fat mass and increasing fat-free mass were found to lower NPNT levels. These findings provide actionable insights into how obesity influences COVID-19 severity.


Subject(s)
COVID-19 , Obesity , Proteome , Humans , COVID-19/genetics , Mendelian Randomization Analysis , Obesity/complications , Obesity/genetics
13.
J Health Commun ; 28(4): 231-240, 2023 Apr 03.
Article in English | MEDLINE | ID: covidwho-2287761

ABSTRACT

The use of social media has changed since the outbreak of coronavirus disease 2019 (COVID-19). However, little is known about the gender disparity in social media use for nonspecific and health-specific issues before and during the COVID-19 pandemic. Based on a gender difference perspective, this study aimed to examine how the nonspecific and health-specific uses of social media changed in 2017-2020. The data came from the Health Information National Trends Survey Wave 5 Cycle 1-4. This study included 10,426 participants with complete data. Compared to 2017, there were higher levels of general use in 2019 and 2020, and an increased likelihood of health-related use in 2020 was reported among the general population. Female participants were more likely to be nonspecific and health-specific users than males. Moreover, the relationship of gender with general use increased in 2019 and 2020; however, concerning health-related use, it expanded in 2019 but narrowed in 2020. The COVID-19 global pandemic led to increased use of social media, especially for health-related issues among males. These findings further our understanding of the gender gap in health communication through social media, and contribute to targeted messaging to promote health and reduce disparities between different groups during the pandemic.


Subject(s)
COVID-19 , Social Media , Male , Humans , Female , COVID-19/epidemiology , Sex Factors , Pandemics , SARS-CoV-2 , Health Promotion
14.
Front Microbiol ; 14: 1043967, 2023.
Article in English | MEDLINE | ID: covidwho-2254595

ABSTRACT

Sequencing technology is the most commonly used technology in molecular biology research and an essential pillar for the development and applications of molecular biology. Since 1977, when the first generation of sequencing technology opened the door to interpreting the genetic code, sequencing technology has been developing for three generations. It has applications in all aspects of life and scientific research, such as disease diagnosis, drug target discovery, pathological research, species protection, and SARS-CoV-2 detection. However, the first- and second-generation sequencing technology relied on fluorescence detection systems and DNA polymerization enzyme systems, which increased the cost of sequencing technology and limited its scope of applications. The third-generation sequencing technology performs PCR-free and single-molecule sequencing, but it still depends on the fluorescence detection device. To break through these limitations, researchers have made arduous efforts to develop a new advanced portable sequencing technology represented by nanopore sequencing. Nanopore technology has the advantages of small size and convenient portability, independent of biochemical reagents, and direct reading using physical methods. This paper reviews the research and development process of nanopore sequencing technology (NST) from the laboratory to commercially viable tools; discusses the main types of nanopore sequencing technologies and their various applications in solving a wide range of real-world problems. In addition, the paper collates the analysis tools necessary for performing different processing tasks in nanopore sequencing. Finally, we highlight the challenges of NST and its future research and application directions.

15.
Comput Struct Biotechnol J ; 21: 2068-2074, 2023.
Article in English | MEDLINE | ID: covidwho-2269827

ABSTRACT

The SARS-CoV-2 virus, which causes the COVID-19, is rapidly accumulating mutations to adapt to the hosts. We collected SARS-CoV-2 sequence data from the end of 2019 to January 2023 to analyze for their evolutionary features during the pandemic. We found that most of the SARS-CoV-2 genes are undergoing negative purifying selection, while the spike protein gene (S-gene) is undergoing rapid positive selection. From the original strain to the alpha, delta and omicron variant types, the Ka/Ks of the S-gene increases, while the Ka/Ks within one variant type decreases over time. During the evolution, the codon usage did not evolve towards optimal translation and protein expression. In contrast, only S-gene mutations showed a remarkable trend on accumulating more positive charges. This facilitates the infection via binding human ACE2 for cell entry and binding furin for cleavage. Such a functional evolution emphasizes the survival strategy of SARS-CoV-2, and indicated new druggable target to contain the viral infection. The nearly fully positively-charged interaction surfaces indicated that the infectivity of SARS-CoV-2 virus may approach a limit.

16.
researchsquare; 2023.
Preprint in English | PREPRINT-RESEARCHSQUARE | ID: ppzbmed-10.21203.rs.3.rs-2838722.v1

ABSTRACT

Objective: Fighting the COVID-19 pandemic requires many citizens to adopt disease-preventive practices. To enhance citizens' vaccination willingness, we explored the impact of national identity and different propaganda slogans on vaccination willingness. Methods: A total of 1098 questionnaires were collected in Study 1, and all participants completed the national identity questionnaire, knowledge of vaccine side effects, vaccine trust, and vaccination willingness. The initial vaccination willingness of the participants (N=804) was measured in Study 2. All participants were then randomly divided into three groups: self-interested, altruistic, and neutral; each group watched the corresponding propaganda video. Each video, which lasted about 11 seconds, consisted of five self-interested, altruistic, or neutral propaganda slogans. Vaccination willingness was then measured again. Results: 1. National identity can significantly predict vaccination willingness in the presence of side effects. 2. The effect of altruistic propaganda slogans on promoting individual vaccination willingness was significantly greater than that of the self-interested propaganda slogan, and the effect of altruistic propaganda slogans on individual vaccination willingness was significantly greater than that of neutral propaganda slogans. Conclusions: National identity, knowledge of vaccine side effects, and vaccine trust can jointly predict individual vaccination willingness in cases of strong national identity. Altruistic slogans have the greatest influence on the change in individuals’ vaccination willingness, and the influence of altruistic propaganda slogans can significantly improve individual vaccination willingness.


Subject(s)
COVID-19 , Encephalomyelitis, Acute Disseminated
17.
Int J Epidemiol ; 2023 Feb 11.
Article in English | MEDLINE | ID: covidwho-2239448

ABSTRACT

OBJECTIVES: Increased iron stores have been associated with elevated risks of different infectious diseases, suggesting that iron supplementation may increase the risk of infections. However, these associations may be biased by confounding or reverse causation. This is important, since up to 19% of the population takes iron supplementation. We used Mendelian randomization (MR) to bypass these biases and estimate the causal effect of iron on infections. METHODS: As instrumental variables, we used genetic variants associated with iron biomarkers in two genome-wide association studies (GWASs) of European ancestry participants. For outcomes, we used GWAS results from the UK Biobank, FinnGen, the COVID-19 Host Genetics Initiative or 23andMe, for seven infection phenotypes: 'any infections', combined, COVID-19 hospitalization, candidiasis, pneumonia, sepsis, skin and soft tissue infection (SSTI) and urinary tract infection (UTI). RESULTS: Most of our analyses showed increasing iron (measured by its biomarkers) was associated with only modest changes in the odds of infectious outcomes, with all 95% odds ratios confidence intervals within the 0.88 to 1.26 range. However, for the three predominantly bacterial infections (sepsis, SSTI, UTI), at least one analysis showed a nominally elevated risk with increased iron stores (P <0.05). CONCLUSION: Using MR, we did not observe an increase in risk of most infectious diseases with increases in iron stores. However for bacterial infections, higher iron stores may increase odds of infections. Hence, using genetic variation in iron pathways as a proxy for iron supplementation, iron supplements are likely safe on a population level, but we should continue the current practice of conservative iron supplementation during bacterial infections or in those at high risk of developing them.

18.
J Infect Public Health ; 16(1): 55-63, 2022 Nov 30.
Article in English | MEDLINE | ID: covidwho-2241548

ABSTRACT

BACKGROUND: Little is known about long-term effectiveness of COVID-19 vaccine in reducing severity and deaths associated with Omicron VOC not perturbed by prior infection and independent of oral anti-viral therapy and non-pharmaceutical (NPI). METHODS: A retrospective observational cohort study was applied to Taiwan community during the unprecedent large-scale outbreaks of Omicron BA.2 between April and August, 2022. Primary vaccination since March, 2021 and booster vaccination since January, 2022 were offered on population level. Oral Anti-viral therapy was also offered as of mid-May 2022. The population-based effectiveness of vaccination in reducing the risk of moderate and severe cases of and death from Omicron BA.2 with the consideration of NPI and oral anti-viral therapy were assessed by using Bayesian hierarchical models. RESULTS: The risks of three clinical outcomes associated with Omicron VOC infection were lowest for booster vaccination, followed by primary vaccination, and highest for incomplete vaccination with the consistent trends of being at increased risk for three outcomes from the young people aged 12 years or below until the elderly people aged 75 years or older with 7 age groups. Before the period using oral anti-viral therapy, complete primary vaccination with the duration more than 9 months before outbreaks conferred the statistically significant 47 % (23-64 %) reduction of death, 48 % (30-61 %) of severe disease, and 46 % (95 % CI: 37-54 %) of moderate disease after adjusting for 10-20 % independent effect of NPI. The benefits of booster vaccination within three months were further enhanced to 76 % (95 % CI: 67-86 %), 74 % (95 % CI: 67-80 %), and 61 % (95 % CI: 56-65 %) for three corresponding outcomes. The additional effectiveness of oral anti-viral therapy in reducing moderate disease was 13 % for the booster group and 5.8 % for primary vaccination. CONCLUSIONS: We corroborated population effectiveness of primary vaccination and its booster vaccination, independent of oral anti-viral therapy and NPI, in reducing severe clinical outcomes associated with Omicron BA.2 naïve infection population.

19.
Stoch Environ Res Risk Assess ; : 1-12, 2022 Sep 11.
Article in English | MEDLINE | ID: covidwho-2239726

ABSTRACT

There is paucity of the statistical model that is specified for data on imported COVID-19 cases with the unique global information on infectious properties of SARS-CoV-2 variant different from local outbreak data used for estimating transmission and infectiousness parameters via the established epidemic models. To this end, a new approach with a four-state stochastic model was proposed to formulate these well-established infectious parameters with three new parameters, including the pre-symptomatic incidence rate, the median of pre-symptomatic transmission time (MPTT) to symptomatic state, and the incidence (proportion) of asymptomatic cases using imported COVID-19 data. We fitted the proposed stochastic model to empirical data on imported COVID-19 cases from D614G to Omicron with the corresponding calendar periods according to the classification GISAID information on the evolution of SARS-CoV-2 variant between March 2020 and Jan 2022 in Taiwan. The pre-symptomatic incidence rate was the highest for Omicron followed by Alpha, Delta, and D614G. The MPTT (in days) increased from 3.45 (first period) ~ 4.02 (second period) of D614G until 3.94-4.65 of VOC Alpha but dropped to 3.93-3.49 of Delta and 2 days (only first period) of Omicron. The proportion of asymptomatic cases increased from 29% of D-614G period to 59.2% of Omicron. Modeling data on imported cases across strains of SARS-CoV-2 not only bridges the link between the underlying natural infectious properties elucidated in the previous epidemic models and different disease phenotypes of COVID-19 but also provides precision quarantine and isolation policy for border control in the face of various emerging SRAS-CoV-2 variants globally.

20.
Swiss Med Wkly ; 152: 40033, 2022 11 21.
Article in English | MEDLINE | ID: covidwho-2237081

ABSTRACT

AIMS: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel virus belonging to the Coronaviridae family that causes coronavirus disease (COVID-19). This disease rapidly reached pandemic status, presenting a serious threat to global health. However, the detailed molecular mechanism contributing to COVID-19 has not yet been elucidated. METHODS: The expression profiles, including the mRNA levels, of samples from patients infected with SARS-CoV-2 along with clinical data were obtained from the GSE152075 dataset in the Gene Expression Omnibus (GEO) database. Weighted gene co-expression network analysis (WGCNA) was used to identify co-expression modules, which were then implemented to evaluate the relationships between fundamental modules and clinical traits. The differentially expressed genes (DEGs), gene ontology (GO) functional enrichment, and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway were evaluated using R software packages. RESULTS: A total of 377 SARS-CoV-2-infected samples and 54 normal samples with available clinical and genetic data were obtained from the GEO database. There were 1444 DEGs identified between the sample types, which were used to screen out 11 co-expression modules in the WGCNA. Six co-expression modules were significantly associated with three clinical traits (SARS-CoV-2 positivity, age, and sex). Among the DEGs in two modules significantly correlated with SARS-CoV-2 positivity, enrichment was observed in the biological process of viral infection strategies (viral translation) in the GO analysis. The KEGG signalling pathway analysis demonstrated that the DEGs in the two modules were commonly enriched in oxidative phosphorylation, ribosome, and thermogenesis pathways. Moreover, a five-core gene set (RPL35A, RPL7A, RPS15, RPS20, and RPL17) with top connectivity with other genes was identified in the SARS-CoV-2 infection modules, suggesting that these genes may be indispensable in viral transcription after infection. CONCLUSION: The identified core genes and signalling pathways associated with SARS-CoV-2 infection can significantly supplement the current understanding of COVID-19. The five core genes encoding ribosomal proteins may be indispensable in viral protein biosynthesis after SARS-CoV-2 infection and serve as therapeutic targets for COVID-19 treatment. These findings can be used as a basis for creating a hypothetical model for future experimental studies regarding associations of SARS-CoV-2 infection with ribosomal protein function.


Subject(s)
COVID-19 Drug Treatment , COVID-19 , Humans , SARS-CoV-2/genetics , COVID-19/genetics , Pandemics , Ribosomal Proteins
SELECTION OF CITATIONS
SEARCH DETAIL